Davita Inc (NYSE:DVA) VP Leanne M. Zumwalt sold 949 shares of the company’s stock in a transaction dated Friday, December 8th. The stock was sold at an average price of $68.19, for a total transaction of $64,712.31. Following the completion of the sale, the vice president now directly owns 12,423 shares of the company’s stock, valued at approximately $847,124.37. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Shares of Davita Inc (NYSE DVA) traded up $0.89 during trading on Wednesday, reaching $70.40. 2,538,900 shares of the company’s stock traded hands, compared to its average volume of 1,661,123. The company has a current ratio of 1.40, a quick ratio of 1.35 and a debt-to-equity ratio of 1.79. Davita Inc has a 12-month low of $52.51 and a 12-month high of $70.58. The company has a market capitalization of $13,153.50, a PE ratio of 19.86, a PEG ratio of 14.01 and a beta of 0.97.

Davita (NYSE:DVA) last issued its quarterly earnings results on Tuesday, November 7th. The company reported $0.81 EPS for the quarter, missing the consensus estimate of $0.94 by ($0.13). Davita had a return on equity of 13.31% and a net margin of 3.40%. The business had revenue of $3.92 billion during the quarter, compared to the consensus estimate of $3.91 billion. During the same quarter last year, the firm posted $0.95 earnings per share. Davita’s revenue was up 5.2% compared to the same quarter last year. equities research analysts anticipate that Davita Inc will post 3.42 EPS for the current fiscal year.

Davita announced that its Board of Directors has approved a stock repurchase program on Tuesday, October 10th that allows the company to repurchase $1.50 billion in outstanding shares. This repurchase authorization allows the company to repurchase shares of its stock through open market purchases. Stock repurchase programs are typically an indication that the company’s management believes its shares are undervalued.

A number of institutional investors have recently modified their holdings of the business. Pzena Investment Management LLC raised its position in Davita by 2.1% in the second quarter. Pzena Investment Management LLC now owns 3,398 shares of the company’s stock worth $220,000 after acquiring an additional 71 shares in the last quarter. Jensen Investment Management Inc. raised its position in Davita by 24.2% in the second quarter. Jensen Investment Management Inc. now owns 9,740 shares of the company’s stock worth $631,000 after acquiring an additional 1,900 shares in the last quarter. Founders Capital Management LLC raised its position in Davita by 2.3% in the third quarter. Founders Capital Management LLC now owns 95,939 shares of the company’s stock worth $5,698,000 after acquiring an additional 2,115 shares in the last quarter. Migdal Insurance & Financial Holdings Ltd. bought a new stake in Davita in the third quarter worth about $154,000. Finally, Eqis Capital Management Inc. raised its position in Davita by 62.5% in the third quarter. Eqis Capital Management Inc. now owns 7,473 shares of the company’s stock worth $444,000 after acquiring an additional 2,873 shares in the last quarter. Hedge funds and other institutional investors own 85.32% of the company’s stock.

Several research firms recently weighed in on DVA. SunTrust Banks set a $57.00 price objective on shares of Davita and gave the stock a “hold” rating in a report on Sunday, October 15th. Royal Bank of Canada reduced their price objective on shares of Davita from $64.00 to $60.00 and set a “sector perform” rating for the company in a report on Wednesday, November 8th. KeyCorp reaffirmed a “hold” rating on shares of Davita in a report on Monday, November 13th. Wolfe Research raised shares of Davita from a “market perform” rating to an “outperform” rating in a report on Monday, October 23rd. Finally, J P Morgan Chase & Co downgraded shares of Davita from a “neutral” rating to an “underweight” rating in a report on Monday, October 9th. Three analysts have rated the stock with a sell rating, five have issued a hold rating, three have issued a buy rating and two have issued a strong buy rating to the stock. Davita currently has a consensus rating of “Hold” and an average target price of $73.33.

TRADEMARK VIOLATION NOTICE: “Davita Inc (DVA) VP Leanne M. Zumwalt Sells 949 Shares of Stock” was reported by Watch List News and is the property of of Watch List News. If you are reading this report on another website, it was copied illegally and reposted in violation of US and international copyright legislation. The correct version of this report can be accessed at https://www.watchlistnews.com/davita-inc-dva-vp-leanne-m-zumwalt-sells-949-shares-of-stock/1761413.html.

About Davita

DaVita Inc, formerly DaVita HealthCare Partners Inc, operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support.

Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with MarketBeat.com's FREE daily email newsletter.